COMMONWEALTH EQUITY SERVICES, LLC

Position in PYXS — Pyxis Oncology, Inc.

CIK 312272 WALTHAM, MA

Position in PYXS

as of Mar 31, 2026 · filed Apr 27, 2026 Compact

Position Value

$50,742

+$5,024 QoQ

Shares Held

34,755

-12.6% QoQ

Ownership

0.055%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#38

of 78 holders

Holding Since

Sep 2023

11 quarters on record

Healthcare · as of Mar 31, 2026

COMMONWEALTH EQUITY SERVICES, LLC holds $113,232,394 across 120 Biotechnology names. PYXS ranks #93 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	54,972	$24,547,196
2	REGN	Regeneron Pharmaceuticals, Inc.	16,385	$12,659,706
3	EXEL	Exelixis, Inc.	173,762	$7,452,652
4	TGTX	Tg Therapeutics, Inc.	180,285	$5,989,067
5	TARS	Tarsus Pharmaceuticals, Inc.	80,892	$5,674,573
6	CRSP	CRISPR Therapeutics AG	78,488	$3,733,674
7	ALNY	Alnylam Pharmaceuticals, Inc.	10,577	$3,499,611
8	ARWR	Arrowhead Pharmaceuticals, Inc.	55,076	$3,453,265

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$50,742	34,755	-12.6%	Shares	Sole	2026-04-27
2025-12-31	$45,718	39,755	-35.0%	Shares	Sole	2026-02-12
2025-09-30	$135,764	61,155	0.0%	Shares	Sole	2025-10-22
2025-06-30	$67,270	61,155	+41.4%	Shares	Sole	2025-08-06
2025-03-31	$42,385	43,250	+64.8%	Shares	Sole	2025-05-09
2024-12-31	$40,950	26,250	+61.5%	Shares	Sole	2025-02-10
2024-09-30	$59,637	16,250	0.0%	Shares	Sole	2024-10-18
2024-06-30	$53,787	16,250	-46.3%	Shares	Sole	2024-07-31
2024-03-31	$128,865	30,250	+133.6%	Shares	Sole	2024-04-29
2023-12-31	$23,310	12,950	0.0%	Shares	Sole	2024-02-06
2023-09-30	$25,770	12,950	—	Shares	Sole	2023-10-23
No filing history on record for this holder in this stock.